ArticleCancer research communications2025

APOBEC3 Activity Promotes the Survival and Evolution of Drug-Tolerant Persister Cells during EGFR Inhibitor Resistance in Lung Cancer.

Nina Marie G Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.